Back to top
more

KORU Medical Systems Inc. (KRMD)

(Delayed Data from NSDQ)

$2.13 USD

2.13
20,306

+0.05 (2.40%)

Updated Apr 22, 2024 11:56 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates

ClearPoint Neuro, Inc. (CLPT) delivered earnings and revenue surprises of 13.64% and 6.41%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

KORU Medical (KRMD) Forms New Deal on Subcutaneous Infusion

One key aspect of the collaboration of KORU Medical (KRMD) with a pharmaceutical manufacturer is the exploration of new therapeutic settings.

Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates

Silk Road Medical (SILK) delivered earnings and revenue surprises of 17.50% and 11.93%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

KORU Medical Systems Inc. (KRMD) Reports Q2 Loss, Tops Revenue Estimates

KORU Medical Systems Inc. (KRMD) delivered earnings and revenue surprises of 0% and 0.09%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Masimo (MASI) Q2 Earnings Miss Estimates

Masimo (MASI) delivered earnings and revenue surprises of -27.91% and 0.18%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Penumbra (PEN) Surpasses Q2 Earnings and Revenue Estimates

Penumbra (PEN) delivered earnings and revenue surprises of 53.57% and 3.28%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates

KORU Medical Systems Inc. (KRMD) delivered earnings and revenue surprises of -25% and 1%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Will KORU Medical Systems Inc. (KRMD) Report Negative Earnings Next Week? What You Should Know

KORU Medical Systems Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

KORU Medical Systems Inc. (KRMD) Reports Q4 Loss, Misses Revenue Estimates

KORU Medical Systems Inc. (KRMD) delivered earnings and revenue surprises of 20% and 1.54%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Paragon 28, Inc. (FNA) Reports Q4 Loss, Tops Revenue Estimates

Paragon 28, Inc. (FNA) delivered earnings and revenue surprises of -466.67% and 2.03%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates

Alphatec (ATEC) delivered earnings and revenue surprises of -10% and 0.23%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Penumbra (PEN) Q4 Earnings and Revenues Surpass Estimates

Penumbra (PEN) delivered earnings and revenue surprises of 14.29% and 1.69%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Sensus Healthcare, Inc. (SRTS) Q4 Earnings and Revenues Lag Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of -34.62% and 1.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Tirthankar Chakraborty headshot

3 Best Breakout Stocks to Invest In Ahead of 2023

KORU Medical Systems (KRMD), Asure Software (ASUR) and YPF Sociedad Anonima (YPF) have been selected as the breakout stocks for today.

KORU Medical Systems Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates

KORU Medical Systems Inc. (KRMD) delivered earnings and revenue surprises of 40% and 11.66%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

DexCom (DXCM) Soars 7.3%: Is Further Upside Left in the Stock?

DexCom (DXCM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

KORU Medical Systems Inc. (KRMD) Reports Q2 Loss, Tops Revenue Estimates

KORU Medical Systems Inc. (KRMD) delivered earnings and revenue surprises of 0% and 4.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Repro Med Systems, Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates

Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 16.67% and 4.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Repro Med Systems, Inc. (KRMD) Reports Q4 Loss, Tops Revenue Estimates

Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 33.33% and 5.89%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Veracyte (VCYT) Reports Q4 Loss, Tops Revenue Estimates

Veracyte (VCYT) delivered earnings and revenue surprises of -7.14% and 6.07%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Silk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates

Silk Road Medical (SILK) delivered earnings and revenue surprises of -5% and 8.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Repro Med Systems, Inc. (KRMD) to Report a Decline in Earnings: What to Look Out for

Repro Med Systems, Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Repro Med Systems, Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates

Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 33.33% and 10.44%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Repro Med Systems, Inc. (KRMD) Q3 Earnings Expected to Decline

Repro Med Systems, Inc. (KRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Repro Med Systems, Inc. (KRMD) Reports Q2 Loss, Tops Revenue Estimates

Repro Med Systems, Inc. (KRMD) delivered earnings and revenue surprises of 33.33% and 10.34%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?